期刊文献+

糖皮质激素在重症社区获得性肺炎中的治疗价值 被引量:4

Therapeutic value of steroids in severe community-acquired pneumonia
原文传递
导出
摘要 目的探讨糖皮质激素在重症社区获得性肺炎(CAP)中的治疗价值。方法回顾性分析上海交通大学附属第六人民医院2009年1月至2010年5月收治的102例重症CAP患者的临床资料,观察激素治疗组(46例)和非激素治疗组(56例)治疗相关指标。结果激素组氧合改善中位时间4 d,非激素组8.5 d,两组比较差异有统计学意义(P<0.05)。激素组体温恢复正常中位时间3 d,较非激素组(4 d)有缩短趋势,但差异无统计学意义(P=0.056)。激素组死亡5例(10.9%),非激素组7例(12.5%),差异无统计学意义(P=0.799)。亚组分析显示呼吸衰竭者接受激素治疗后住院时间与未接受激素治疗者相似(P=0.208),非呼吸衰竭者接受激素治疗后住院时间延长(P=0.025)。两组副反应发生率差异无统计学意义(P>0.05)。结论糖皮质激素治疗可加快重症CAP患者氧合的改善、体温的恢复,但不降低住院时间和病死率。哪些患者可从激素治疗中获益以及激素的最佳剂量和疗程仍需进一步研究。 Objective To evaluate the value of steroids in the treatment of severe community-acquired pneu- monia (CAP). Methods The clinical data from 102 patients with severe CAP registered to the Shanghai Sixth People's Hospital between January 2009 and May 2010 were reviewed. These patients were assigned to two groups depending on use of steroids, the steroids group ( n = 46) and non-steroids group ( n = 56). Results The median time to improved oxygenation was 4 days in the teroids group vs 8. 5 days in the non-steroids group, reaching significant level of statistical difference ( P 〈 0. 05 ). The median time to recovery of normal body temperature appeared shorter in the steroids group (3 days) compared with non-steroids group (4 days), but this was not statistically significant (P =0. 056). The death from severe CAP was comparable between the steroids (n = 5,10. 9% ) and non-steroids (n=7,12. 5% ) groups. A subgroup analysis, the length of hospital stay was comparable between patients with respiratory failure on steroids and those not on steroids (P = 0. 208 ) , but was longer in patients without respiratory failure on steroids than in those not on steroids (P = 0. 025 ). The incidence of adverse events were similar between groups ( P 〉 0. 05 ). Conclusion Treatment with steroids may be associated with quicker improvement in oxygenation and recovery in body temperature among patients with severe CAP, but not with length of hospital stay and death. Identification of patients who can benefit from steroids therapy, optimal dose and course of steroids should warrant further study.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2011年第11期856-858,共3页 Chinese Journal of Practical Internal Medicine
关键词 社区获得性肺炎 糖皮质激素 community-acquired pneumonia steroids
  • 相关文献

参考文献9

  • 1Sibila O, Agusti C, Torres A. Cortieosteroids in severe pneumonia[J]. Eur Respir J,2008,32(2) :259 -264. 被引量:1
  • 2Annane D,Maxime V,Ibrahim F,et al. Diagnosis of Adrenal Insufficiency in Severe Sepsis and Septic Shock [ J]. Am J Respir Crit Care Med,2006,174(12) :1319 - 1326. 被引量:1
  • 3de Jong MF, Beishuizen A, Spijkstra J J, et al. Relative adrenal insufficiency as a predictor of disease severity,mortality,and benefi- cial effects of corticosteroid treatment in septic shock [ J ]. Crit Care Med,2007,35 ( 8 ) : 1896 - 1903. 被引量:1
  • 4社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3048
  • 5Confalonieri M, Urbino R, Pntena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia. A preliminary randomized study [J]. Am J Respir Crit Care Meal,2005,171 (3) :242 - 248. 被引量:1
  • 6Garcia-Vidal C, Calbo E, Pascual V, et al. Effects of systemic ster- oids in patients with severe community-acquired pneumonia [ J ]. Eur Respir J,2007,30 ( 5 ) :951 - 956. 被引量:1
  • 7Snijders D, Daniels JM,de Graaff CS, et al. Efficacy of Corticosteroids in Community-acquired Pneumonia. A Randomized Double- Blinded Clinical Trial [J]. Am J Respir Crit Care Med,2010,181 (9) :975 -982. 被引量:1
  • 8Salluh JI, Povoa P, Soares M, et al. The role of corticosteroids in severe community-acquired pnemnonia : a systematic review[J]. Crit Care,2008,12(3 ) :R76. 被引量:1
  • 9Kiyokawa K, Kawai S. Efficacy of steroid therapy on adult patients with severe pneumonia[J]. J Infect Chemother,2010,16 (4) :266 -271. 被引量:1

二级参考文献24

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:787
  • 3Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153. 被引量:1
  • 4de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351. 被引量:1
  • 5Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659. 被引量:1
  • 6Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936. 被引量:1
  • 7Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421. 被引量:1
  • 8Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180. 被引量:1
  • 9Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433. 被引量:1
  • 10Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250. 被引量:1

共引文献3047

同被引文献35

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部